AAAAAA

   
Results: 1-18 |
Results: 18
ECONOMISATION OF VACCINATION AGAINST HAEMOPHILUS-INFLUENZAE TYPE-B - A RANDOMIZED TRIAL OF IMMUNOAFFINITY OF FRACTIONAL-DOSE AND 2-DOSE REGIMENS
Authors: LAGOS R VALENZUELA MT LEVINE OS LOSONSKY GA ERAZO A WASSERMAN SS LEVINE MM
Citation: R. Lagos et al., ECONOMISATION OF VACCINATION AGAINST HAEMOPHILUS-INFLUENZAE TYPE-B - A RANDOMIZED TRIAL OF IMMUNOAFFINITY OF FRACTIONAL-DOSE AND 2-DOSE REGIMENS, Lancet, 351(9114), 1998, pp. 1472-1476
A SINGLE-DOSE OF LIVE ORAL CHOLERA VACCINE CVD 103-HGR IS SAFE AND IMMUNOGENIC IN HIV-INFECTED AND HIV-NONINFECTED ADULTS IN MALI
Authors: PERRY RT PLOWE CV KOUMARE B BOUGOUDOGO F KOTLOFF KL LOSONSKY GA WASSERMAN SS LEVINE MM
Citation: Rt. Perry et al., A SINGLE-DOSE OF LIVE ORAL CHOLERA VACCINE CVD 103-HGR IS SAFE AND IMMUNOGENIC IN HIV-INFECTED AND HIV-NONINFECTED ADULTS IN MALI, Bulletin of the World Health Organization, 76(1), 1998, pp. 63-71
VALIDATION OF A VOLUNTEER MODEL OF CHOLERA WITH FROZEN BACTERIA AS THE CHALLENGE
Authors: SACK DA TACKET CO COHEN MB SACK RB LOSONSKY GA SHIMKO J NATARO JP EDELMAN R LEVINE MM GIANNELLA RA SCHIFF G LANG D
Citation: Da. Sack et al., VALIDATION OF A VOLUNTEER MODEL OF CHOLERA WITH FROZEN BACTERIA AS THE CHALLENGE, Infection and immunity, 66(5), 1998, pp. 1968-1972
VIBRIOCIDAL ANTIBODY-RESPONSES IN NORTH-AMERICAN VOLUNTEERS EXPOSED TO WILD-TYPE OR VACCINE VIBRIO-CHOLERAE O139 - SPECIFICITY AND RELEVANCE TO IMMUNITY
Authors: LOSONSKY GA LIM Y MOTAMEDI P COMSTOCK LE JOHNSON JA MORRIS JG TACKET CO KAPER JB LEVINE MM
Citation: Ga. Losonsky et al., VIBRIOCIDAL ANTIBODY-RESPONSES IN NORTH-AMERICAN VOLUNTEERS EXPOSED TO WILD-TYPE OR VACCINE VIBRIO-CHOLERAE O139 - SPECIFICITY AND RELEVANCE TO IMMUNITY, Clinical and diagnostic laboratory immunology, 4(3), 1997, pp. 264-269
A MURINE MODEL OF INTRANASAL IMMUNIZATION TO ASSESS THE IMMUNOGENICITY OF ATTENUATED SALMONELLA-TYPHI LIVE VECTOR VACCINES IN STIMULATING SERUM ANTIBODY-RESPONSES TO EXPRESSED FOREIGN ANTIGENS
Authors: GALEN JE GOMEZDUARTE OG LOSONSKY GA HALPERN JL LAUDERBAUGH CS KAINTUCK S REYMANN MK LEVINE MM
Citation: Je. Galen et al., A MURINE MODEL OF INTRANASAL IMMUNIZATION TO ASSESS THE IMMUNOGENICITY OF ATTENUATED SALMONELLA-TYPHI LIVE VECTOR VACCINES IN STIMULATING SERUM ANTIBODY-RESPONSES TO EXPRESSED FOREIGN ANTIGENS, Vaccine, 15(6-7), 1997, pp. 700-708
SAFETY OF LIVE ORAL SALMONELLA-TYPHI VACCINE STRAINS WITH DELETIONS IN HTRA AND AROC AROD AND IMMUNE-RESPONSE IN HUMANS
Authors: TACKET CO SZTEIN MB LOSONSKY GA WASSERMAN SS NATARO JP EDELMAN R PICKARD D DOUGAN G CHATFIELD SN LEVINE MM
Citation: Co. Tacket et al., SAFETY OF LIVE ORAL SALMONELLA-TYPHI VACCINE STRAINS WITH DELETIONS IN HTRA AND AROC AROD AND IMMUNE-RESPONSE IN HUMANS, Infection and immunity, 65(2), 1997, pp. 452-456
NO ADVERSE IMPACT ON PROTECTION AGAINST PERTUSSIS FROM COMBINED ADMINISTRATION OF HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE AND DIPHTHERIA-TETANUS TOXOID-PERTUSSIS VACCINES IN THE SAME SYRINGE
Authors: LEVINE OS LAGOS R LOSONSKY GA MARTIN OS ABREGO P BUSTAMANTE C WASSERMAN SS LEVINE MM
Citation: Os. Levine et al., NO ADVERSE IMPACT ON PROTECTION AGAINST PERTUSSIS FROM COMBINED ADMINISTRATION OF HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE AND DIPHTHERIA-TETANUS TOXOID-PERTUSSIS VACCINES IN THE SAME SYRINGE, The Journal of infectious diseases, 174(6), 1996, pp. 1341-1344
VIBRIO-CHOLERAE-01 CAN ASSUME A CHLORINE-RESISTANT RUGOSE SURVIVAL FORM THAT IS VIRULENT FOR HUMANS
Authors: MORRIS JG SZTEIN MB RICE EW NATARO JP LOSONSKY GA PANIGRAHI P TACKET CO JOHNSON JA
Citation: Jg. Morris et al., VIBRIO-CHOLERAE-01 CAN ASSUME A CHLORINE-RESISTANT RUGOSE SURVIVAL FORM THAT IS VIRULENT FOR HUMANS, The Journal of infectious diseases, 174(6), 1996, pp. 1364-1368
SAFETY, IMMUNOGENICITY, AND TRANSMISSIBILITY IN HUMANS OF CVD-1203, ALIVE ORAL SHIGELLA-FLEXNERI-2A VACCINE CANDIDATE ATTENUATED BY DELETIONS IN AROA AND VIRG
Authors: KOTLOFF KL NORIEGA F LOSONSKY GA SZTEIN MB WASSERMAN SS NATARO JP LEVINE MM
Citation: Kl. Kotloff et al., SAFETY, IMMUNOGENICITY, AND TRANSMISSIBILITY IN HUMANS OF CVD-1203, ALIVE ORAL SHIGELLA-FLEXNERI-2A VACCINE CANDIDATE ATTENUATED BY DELETIONS IN AROA AND VIRG, Infection and immunity, 64(11), 1996, pp. 4542-4548
FACTORS INFLUENCING SECONDARY VIBRIOCIDAL IMMUNE-RESPONSES - RELEVANCE FOR UNDERSTANDING IMMUNITY TO CHOLERA
Authors: LOSONSKY GA YUNYONGYING J LIM V REYMANN M LIM YL WASSERMAN SS LEVINE MM
Citation: Ga. Losonsky et al., FACTORS INFLUENCING SECONDARY VIBRIOCIDAL IMMUNE-RESPONSES - RELEVANCE FOR UNDERSTANDING IMMUNITY TO CHOLERA, Infection and immunity, 64(1), 1996, pp. 10-15
EVALUATION OF THE SAFETY, IMMUNOGENICITY, AND EFFICACY IN HEALTHY-ADULTS OF 4 DOSES OF LIVE ORAL HYBRID ESCHERICHIA-COLI SHIGELLA-FLEXNERI 2A VACCINE STRAIN ECSF2A-2
Authors: KOTLOFF KL LOSONSKY GA NATARO JP WASSERMAN SS HALE TL TAYLOR DN NEWLAND JW SADOFF JC FORMAL SB LEVINE MM
Citation: Kl. Kotloff et al., EVALUATION OF THE SAFETY, IMMUNOGENICITY, AND EFFICACY IN HEALTHY-ADULTS OF 4 DOSES OF LIVE ORAL HYBRID ESCHERICHIA-COLI SHIGELLA-FLEXNERI 2A VACCINE STRAIN ECSF2A-2, Vaccine, 13(5), 1995, pp. 495-502
A MODIFIED SHIGELLA VOLUNTEER CHALLENGE MODEL IN WHICH THE INOCULUM IS ADMINISTERED WITH BICARBONATE BUFFER - CLINICAL-EXPERIENCE AND IMPLICATIONS FOR SHIGELLA INFECTIVITY
Authors: KOTLOFF KL NATARO JP LOSONSKY GA WASSERMAN SS HALE TL TAYLOR DN SADOFF JC LEVINE MM
Citation: Kl. Kotloff et al., A MODIFIED SHIGELLA VOLUNTEER CHALLENGE MODEL IN WHICH THE INOCULUM IS ADMINISTERED WITH BICARBONATE BUFFER - CLINICAL-EXPERIENCE AND IMPLICATIONS FOR SHIGELLA INFECTIVITY, Vaccine, 13(16), 1995, pp. 1488-1494
PRELIMINARY-RESULTS EVALUATING THE IMMUNOGENICITY OF HEPATITIS-B VACCINATION OF PREMATURE-INFANTS STARTING IN THE 1ST WEEK OF LIFE
Authors: LOSONSKY GA STEPHENS I MAHONEY F WASSERMAN S GEWOLB I LAMBERT S DULKERIAN S
Citation: Ga. Losonsky et al., PRELIMINARY-RESULTS EVALUATING THE IMMUNOGENICITY OF HEPATITIS-B VACCINATION OF PREMATURE-INFANTS STARTING IN THE 1ST WEEK OF LIFE, Pediatric research, 37(4), 1995, pp. 295-295
SERUM ANTIBODY-RESPONSES OF DIVERS TO WATERBORNE PATHOGENS
Authors: LOSONSKY GA HASAN JAK HUQ A KAINTUCK S COLWELL RR
Citation: Ga. Losonsky et al., SERUM ANTIBODY-RESPONSES OF DIVERS TO WATERBORNE PATHOGENS, Clinical and diagnostic laboratory immunology, 1(2), 1994, pp. 182-185
SUCCESSFUL TREATMENT OF MENINGITIS DUE TO MULTIPLY RESISTANT ENTEROCOCCUS-FAECIUM WITH A COMBINATION OF INTRATHECAL TEICOPLANIN AND INTRAVENOUS ANTIMICROBIAL AGENTS
Authors: LOSONSKY GA WOLF A SCHWALBE RS NATARO J GIBSON CB LEWIS EW
Citation: Ga. Losonsky et al., SUCCESSFUL TREATMENT OF MENINGITIS DUE TO MULTIPLY RESISTANT ENTEROCOCCUS-FAECIUM WITH A COMBINATION OF INTRATHECAL TEICOPLANIN AND INTRAVENOUS ANTIMICROBIAL AGENTS, Clinical infectious diseases, 19(1), 1994, pp. 163-165
KINETICS OF THE VIBRIOCIDAL ANTIBODY-RESPONSE TO LIVE ORAL CHOLERA VACCINES
Authors: WASSERMAN SS LOSONSKY GA NORIEGA F TACKET CO CASTANEDA E LEVINE MM
Citation: Ss. Wasserman et al., KINETICS OF THE VIBRIOCIDAL ANTIBODY-RESPONSE TO LIVE ORAL CHOLERA VACCINES, Vaccine, 12(11), 1994, pp. 1000-1003
A COMPARATIVE-EVALUATION OF THE SAFETY AND IMMUNOGENICITY OF A SINGLE-DOSE OF UNBUFFERED ORAL RHESUS ROTAVIRUS SEROTYPE-3, RHESUS HUMAN REASSORTANT SEROTYPE-1, SEROTYPE-2 AND SEROTYPE-4 AND COMBINED (TETRAVALENT) VACCINES IN HEALTHY INFANTS
Authors: PICHICHERO ME MARSOCCI SM FRANCIS AB GREEN JL DISNEY FA RENNELS MB LEWIS ED SUGARMAN L LOSONSKY GA ZITO E DAVIDSON BL
Citation: Me. Pichichero et al., A COMPARATIVE-EVALUATION OF THE SAFETY AND IMMUNOGENICITY OF A SINGLE-DOSE OF UNBUFFERED ORAL RHESUS ROTAVIRUS SEROTYPE-3, RHESUS HUMAN REASSORTANT SEROTYPE-1, SEROTYPE-2 AND SEROTYPE-4 AND COMBINED (TETRAVALENT) VACCINES IN HEALTHY INFANTS, Vaccine, 11(7), 1993, pp. 747-753
IMMUNOLOGICAL RESPONSE TO ORAL CHOLERA VACCINATION IN A CROSSOVER STUDY - A NOVEL PLACEBO-EFFECT
Authors: WASSERMAN SS KOTLOFF KL LOSONSKY GA LEVINE MM
Citation: Ss. Wasserman et al., IMMUNOLOGICAL RESPONSE TO ORAL CHOLERA VACCINATION IN A CROSSOVER STUDY - A NOVEL PLACEBO-EFFECT, American journal of epidemiology, 138(11), 1993, pp. 988-993
Risultati: 1-18 |